NCT03005873 - Phase IIa, Randomized, Double Blinded, Placebo Controlled, Dose Finding Study for TLC599 in OA Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 16, 2017

Primary Completion Date

July 4, 2018

Study Completion Date

July 4, 2018

Conditions

Osteoarthritis of the Knee

Interventions

DRUG

TLC599 LD group

Single dose via intra-articular injection

DRUG

Normal Saline

Single dose via intra-articular injection

DRUG

TLC599 HD group

Single dose via intra-articular injection

Trial Locations (13)

Chung Shan Medical University Hosptial, Taichung

Pendlebury Clinic Private Hospital, Cardiff

Genesis Research Services Pty Limited, Broadmeadow

Footscray Hospital- Western Health, Footscray

Linear Clinical Research Limited, Nedlands

Royal North Shore Hospital, Sydney

Show Chwan Memorial Hospital, Changhua

Kaohsiung Medical University Hospital, Kaohsiung City

China Medical University Hospital, Taichung

Taichung Veterans General Hospital, Taichung

Cheng Hsin General Hospital, Taipei

Shin Kong Wu Ho-Su Memorial Hospital, Taipei

Taipei Medical Universtiy Hospital, Taipei